- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
The UK BioIndustry Association's Vision for the Sector in 2025
April 28, 2015.
The UK BioIndustry Association (BIA) has launched its vision for the UK life sciences sector in 2025. Setting out a goal for the UK to become a top global cluster in life sciences, the BIA envisions that by 2025 the country could see
• four times as many drugs and other innovations into clinic and to patients
• private investment of £2.9 bn (US$4.4 bn) per annum (£2.6bn per annum more than today)
• 130 more clinical stage drug companies and management teams
• 30,000-60,000 additional high skill UK jobs
• a salary pool that is £10 bn (US$15.2 bn) per annum more than today.
Steve Bates, CEO of the BIA commented: “This thoughtful analysis is an industry inspired vision of the potential prize for our sector. The UK truly has the potential to be a world leader in biotech, a key part of the economy of the future. We need to match world class financing and company growth capacities to our world class capabilities in science.”
The BIA document, A vision for the life sciences sector in 2025, can be downloaded here.
